search
Back to results

Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery

Primary Purpose

Fasting, Feeding, Time Restricted, Stress-related Problem

Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Enteral nutrition formula
Sponsored by
E-DA Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fasting

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Advanced head-and-neck cancer
  • Requires radical resection, tracheostomy and free flap reconstruction surgery

Exclusion Criteria:

  • Anticipated total operation time < 6h
  • Emergency operation
  • Bowel obstruction
  • Starts nasogastric feeding before operation

Sites / Locations

  • E-Da Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group

Intraoperative feeding group

Arm Description

Patients assigned to control group will not receive feeding via the nasogastric tube during operation

Patients assigned to intraoperative feeding group will receive enteral nutrition formula via the nasogastric tube during operation

Outcomes

Primary Outcome Measures

Number of participants that have reconstruction flap failure after operation
The definition of flap failure includes vascular occlusion of flap, surgical wound infection or poor healing that requires surgical reintervention

Secondary Outcome Measures

Number of participants that have perioperative complications
The definition of composite perioperative complications during and after operation, include intraoperative hemodynamic stability (hypotension and requirement of inotropes), postoperative insulin sensitivity, glycemic control, skeletal muscle wasting, inflammatory cytokine profiles, length of hospital stay, re-intervention, other postoperative complications, mortality during hospital stay

Full Information

First Posted
February 10, 2020
Last Updated
April 13, 2022
Sponsor
E-DA Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04266015
Brief Title
Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery
Official Title
A Randomized Trial of Intraoperative Feeding to Ameliorate Catabolic Response in Free Flap Reconstruction Surgery for Head-and-neck Cancer Defect
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
April 16, 2020 (Actual)
Primary Completion Date
January 10, 2022 (Actual)
Study Completion Date
April 13, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
E-DA Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Perioperative fasting remains a common clinical practice in surgical patients to prevent the development of postoperative anesthesia- and surgical-related complications. Clinical observational studies indicated that the combination catabolic effects resulted from prolonged perioperative fasting and profound surgical stress are likely to induce extensive protein catabolism, muscle breakdown and impaired glycemic control during postoperative phase, leading to the development of severe complications. Furthermore, prolonged gastrointestinal fasting is associated with microbial translocation that deteriorates the early recovery after surgery. This clinical trial anticipates in determining the beneficial effect of intraoperative feeding to improve intraoperative hemodynamics and enhance postoperative recovery due to attenuation of systemic catabolism and improvement of insulin sensitivity to glycemic control.
Detailed Description
Perioperative fasting remains a common clinical practice in surgical patients, aiming to prevent pulmonary aspiration during anesthesia induction, improve bowel preparation, and ameliorate the development of postoperative nausea/vomiting or other surgical-related complications. Major head-and-neck tumor excision and reconstruction surgery is one of the most time-consuming surgeries that usually takes more than 12 h to complete. In addition to the preoperative fasting and postoperative recovery time periods, most of these patients will be fasted for more than 24-36 h before they are fed via nasogastric tubes in the postoperative care units. The combination catabolic effects resulted from prolonged perioperative fasting and profound surgical stress are likely to induce extensive protein catabolism, muscle breakdown and impaired glycemic control during postoperative phase. These catabolic responses may lead to the development of post-operative surgical site infection, delayed wound healing, re-intervention, cardiac arrest, and death in diabetic and non-diabetic patients. Furthermore, prolonged gastrointestinal fasting is associated with dehydration, perturbed gut integrity/permeability (leaky gut) and microbial (bacterial) translocation that deteriorates the early recovery after reconstruction surgery. The aim of this clinical trial is to test the effect of intraoperative feeding in patients receiving head-and-neck tumor excision and reconstruction surgery, and anticipate that reduction of perioperative fasting time may improve intraoperative hemodynamics and enhance postoperative recovery due to attenuation of systemic catabolism and improvement of insulin sensitivity to glycemic control. This single-center clinical trial will be undertaken in a randomized, double-blind, placebo-controlled fashion, in which patients with advanced head-and-neck tumor who are scheduled for extended tumor resection and free-flap reconstruction will be randomly assigned to receive control (no intraoperative feeding) or intraoperative feeding group. Feeding via the nasogastric (NG) tube will start after the establishment of tracheostomy and completion of tumor resection at fusion rate of 10-30 ml/h (feeding diet 1 Kcal/ml and 0.04 g protein/ml). This trial anticipates in detecting differences in intraoperative hemodynamic stability and development of major postoperative complications, including delayed wound healing, surgical site infections and insulin-resistant hyperglycemia between controls and intraoperative feeding group. The outcomes of this clinical trial may provide fundamental evidence for vigorous enteric nutrition and energy support during prolonged high surgical stress operation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fasting, Feeding, Time Restricted, Stress-related Problem, Head and Neck Neoplasms, Catabolic State, Hyperglycemia Stress, Muscle Wasting, Complication,Postoperative

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized double-blind controlled trial
Masking
ParticipantCare Provider
Masking Description
Participants: patients will receive general anesthesia before intervention Care providers: surgeons will be masked of the treatment group during operation
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Patients assigned to control group will not receive feeding via the nasogastric tube during operation
Arm Title
Intraoperative feeding group
Arm Type
Experimental
Arm Description
Patients assigned to intraoperative feeding group will receive enteral nutrition formula via the nasogastric tube during operation
Intervention Type
Dietary Supplement
Intervention Name(s)
Enteral nutrition formula
Intervention Description
Intervention group will receive nasogastric feeding with commercially available liquid enteral diet (250 ml/can, Kcal/ml, 10.4 g protein/can) during free flap reconstruction at feeding rates 10-30 ml/h.
Primary Outcome Measure Information:
Title
Number of participants that have reconstruction flap failure after operation
Description
The definition of flap failure includes vascular occlusion of flap, surgical wound infection or poor healing that requires surgical reintervention
Time Frame
7 days after free flap reconstruction
Secondary Outcome Measure Information:
Title
Number of participants that have perioperative complications
Description
The definition of composite perioperative complications during and after operation, include intraoperative hemodynamic stability (hypotension and requirement of inotropes), postoperative insulin sensitivity, glycemic control, skeletal muscle wasting, inflammatory cytokine profiles, length of hospital stay, re-intervention, other postoperative complications, mortality during hospital stay
Time Frame
Start of free flap reconstruction surgery to 28 days after operation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Advanced head-and-neck cancer Requires radical resection, tracheostomy and free flap reconstruction surgery Exclusion Criteria: Anticipated total operation time < 6h Emergency operation Bowel obstruction Starts nasogastric feeding before operation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chen-Fuh Lam, MD, PhD
Organizational Affiliation
E-Da Hospital, Taiwan
Official's Role
Principal Investigator
Facility Information:
Facility Name
E-Da Hospital
City
Yanchao
State/Province
Kaohsiung
ZIP/Postal Code
824
Country
Taiwan

12. IPD Sharing Statement

Learn more about this trial

Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery

We'll reach out to this number within 24 hrs